In this environment, CXCL12, secreted by cancer-associated fibroblasts (CAFs) and mesenchymal stem cells, binds to the CXCR4 protein expressed on TNBC cells and immune cells, leading to the activation of signalling pathways, which promote an immunosuppressive tumour environment [83]. This evidence concerns the gene CXCR4 and neoplasm.